Rize
Rize
Rize, Turkey (Türkiye)24 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-10-09 | NCT07554339 | |
| A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prostatic Cancer, Castration-Resistant, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06863272 | |
| A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction | Digestive System Diseases, Fatigue, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT07304843 | |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 3 | 2026-10-08 | NCT07165028 | |
| A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07060807 | |
| MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2026-10-07 | NCT07431827 | |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis | MASH With Fibrosis; NASH With Fibrosis | Recruiting | Phase 3 | 2026-10-06 | NCT06215716 | |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis | Metabolic Dysfunction Associated Steatohepatitis | Recruiting | Phase 3 | 2026-10-01 | NCT06632457 | |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis | Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Phase 3 | 2026-10-01 | NCT06632444 | |
| A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease | Recruiting | Phase 3 | 2026-09-21 | NCT06528314 | |
| Phase 2b Study of GSK4532990 in Adults With NASH | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 2 | 2026-09-18 | NCT05583344 | |
| HBV Reactivation in Immunocompromised Patients (REANT STUDY) | HBV | Recruiting | Not stated | 2026-08-04 | NCT07529171 | |
| Effect of Dental Education Duration on Halitosis and Associated Factors | Halitosis, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive | Not yet recruiting | Not stated | 2026-08-03 | NCT07740876 | |
| Interoceptive Awareness and Dream Themes | Dyssomnias, Medically Unexplained Symptoms, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Active, not recruiting | Not stated | 2026-07-21 | NCT07716514 | |
| Swaddling and Facilitated Tucking During Nasal CPAP Application | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-07-20 | NCT07077148 | |
| Evaluation of the Effect of Hyperuricemia on Alveolar Bone Loss | Alveolar Bone Loss, Hyperuricemia, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Periodontal Atrophy, Stomatognathic Diseases, bone disorder, bone resorption disease, mouth disorder, musculoskeletal system disorder, periodontal disorder | Recruiting | Not stated | 2026-06-26 | NCT07666126 | |
| Anti-inflammatory Nutrition on the Outcomes of Non-surgical Periodontal Therapy | Stomatognathic Diseases, mouth disorder, periodontal disorder, periodontitis | Recruiting | Not stated | 2026-06-23 | NCT07287540 | |
| The Effect of Vitamin D Supplementation on the Anti-inflammatory Response in Periodontal Diseases | Infections, Nutritional and Metabolic Diseases, Stomatognathic Diseases, gingival disorder, gingivitis, mouth disorder, nutritional deficiency disease, nutritional disorder, periodontal disorder, periodontitis, vitamin D deficiency, vitamin deficiency disorder | Recruiting | Not applicable | 2026-06-10 | NCT07636733 | |
| A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Active, not recruiting | Phase 3 | 2026-04-30 | NCT06161571 | |
| MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) | Arterial Occlusive Diseases, Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, heart valve disorder, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-03-30 | NCT05487612 | |
| Body Awareness-Based Rehabilitation on Physical Psychosocial Status in Patellofemoral Pain Syndrome | arthropathy, musculoskeletal system disorder, patellofemoral pain syndrome | Not yet recruiting | Not applicable | 2026-02-13 | NCT07411027 | |
| The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders | Craniomandibular Disorders, Jaw Diseases, Mandibular Diseases, Stomatognathic Diseases, arthropathy, muscle tissue disorder, musculoskeletal system disorder, temporomandibular joint disorder | Recruiting | Not applicable | 2026-02-03 | NCT07317570 | |
| Clinical Comparison of Restorative Materials | Stomatognathic Diseases, Tooth Demineralization, dental caries, tooth disorder | Active, not recruiting | Not stated | 2026-01-07 | NCT06637605 | |
| Pressure Recording Analytical Method Parameters and Their Relationship With Hypotension in Hypertensive Patients | cardiovascular disorder, hypotensive disorder, vascular disorder | Recruiting | Not stated | 2025-04-09 | NCT05960604 |